Elyssa N Denault

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

A. Iafrate, A. Bardia, H. Willers, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

W. Gradishar, R. Bose, A. Bardia, 2022, EBioMedicine.

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

G. Getz, A. Bardia, A. Kambadakone, 2021, Cancer discovery.

Circulating Tumor DNA in Breast Cancer: Current and Future Applications.

A. Bardia, B. Moy, H. Parsons, 2023, Clinical breast cancer.

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

A. Iafrate, A. Bardia, D. Juric, 2022, Therapeutic advances in medical oncology.

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer

A. Iafrate, A. Bardia, H. Willers, 2021, Cancer Cell.

Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses

Christine E. Edmonds, M. Specht, C. Lehman, 2021, npj Precision Oncology.